Skip to main content
Livermore
Livermore
ZHEN

Otonomy, Inc.

OTICDelisted Dec 29, 2022
Industry
Pharmaceutical Preparations
SEC CIK
0001493566

Otonomy, Inc. was delisted on Dec 29, 2022; its insiders filed their last Form 4 on Dec 30, 2022; 40 institutions reported holding it in 13F filings for Q3 2022, worth $8.42M in total; no superinvestor held it.

Holders of 5% or more of OTIC

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Otonomy, Inc., largest stake first. The change is against the holder's previous filing.

No holder currently reports owning 5% or more of Otonomy, Inc. on Schedule 13D or 13G.

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

10 Schedule 13D and 13G filings on Otonomy, Inc., newest first, including old-format filings without a stake.

Schedule 13D and 13G filings on OTIC
Filed (ET)FilerFormStakeChangeEvent dateFiling
Feb 16, 2021Weber David Allen13G/AOld format–––SEC
Feb 16, 2021First Manhattan Co13G/AOld format–––SEC
Feb 16, 2021Sofinnova Investments, Inc.13GOld format–New–SEC
Feb 16, 2021Cormorant Asset Management, LP13G/AOld format–––SEC
Feb 16, 2021Point72 Asset Management, L.P.13G/AOld format–––SEC
Feb 12, 2021TPG Group Holdings (SBS) Advisors, Inc.13G/AOld format–––SEC
Feb 12, 2021OrbiMed Advisors LLC13GOld format–New–SEC
Feb 11, 2021Renaissance Technologies LLC13G/AOld format–––SEC
Feb 10, 20212:41 PM ETFederated Hermes, Inc.13G/AOld format–––SEC
Feb 10, 202112:57 PM ETFederated Hermes, Inc.13G/AOld format–––SEC

Form 144: proposed insider sales

Notices from officers, directors and other affiliates planning to sell Otonomy, Inc. shares.

No Form 144 notices for Otonomy, Inc. are on file.